Health Care/Hospital

Bridgewest Perth Pharma gains strategic edge with noted Australian Executive John Van Der Wielen on Board

PERTH, Australia, July 2, 2024 /PRNewswire/ -- Bridgewest Perth Pharma, global pharmaceutical holding company withNovaCina CDMO division and LumaCina  pharmaceutical supply division, announces the addition of renown Australian executiveJohn Van Der Wielen to Board of Directors. Van Der Wielen will...

2024-07-02 07:00 2092

Datasea Enters into New Sales Agreements for its 5G AI Communications and High Tech Acoustic Segments Expecting $62 Million in Sales

The Three Agreements Support Continued Fiscal Year 2025 Revenue Growth for its Core AI-Based Businesses BEIJING, July 1, 2024 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), aNevada corporation engaged in innovative businesses in high-tech intelligent acoustics and 5G-A...

2024-07-01 21:30 4226

JCI Publishes 8th Edition of International Accreditation Standards for Hospitals and Academic Medical Centers

8th edition strengthens existing standards to advance patient safety and quality improvement OAKBROOK TERRACE, Ill., July 1, 2024 /PRNewswire/ -- Joint Commission International (JCI) has released the 8th edition of its Accreditation Standards for Hospitals and Academic Medical Centers. These evi...

2024-07-01 21:00 2054

HistoIndex Charts New Course in Liver Disease Innovation: Announces Pivotal Changes to Scientific Advisory Board

* Company to appoint Prof. Arun J. Sanyal as the new Chairman of HistoIndex's Scientific Advisory Board, bringing unparalleled expertise to guide future innovations. * Prof. Vlad Ratziu joins the Scientific Advisory Board to strengthen the Company's global scientific leadership in liver disea...

2024-07-01 20:00 2565

Ping An Co-CEO Michael Guo at "Summer Davos": Low Public Awareness of Financial Planning for Senior Care in China is Opportunity for Financial Services Industry

HONG KONG and SHANGHAI, July 1, 2024 /PRNewswire/ -- China's growing senior population is bringing tremendous business opportunities to the financial services industry, says Michael Guo, Co-CEO of Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An", the "Company" or the "Group", ...

2024-07-01 19:19 4651

Meihua International Medical Technologies Co., Ltd. Announces Share Repurchase Program of Up to $3 million

YANGZHOU, China, July 1, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (Nasdaq: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries inChina, announced today that its board o...

2024-07-01 18:00 1910

"Twenty Years of Collaboration Leading to New Success" - The 20th Anniversary Press Conference of Medtec China Successfully Held in Shanghai

SHANGHAI, July 1, 2024 /PRNewswire/ -- On the morning of June 26, 2024, the  20th Anniversary Press Conference of Medtec China was successfully held at the Grand Kempinski Hotel Shanghai. Mr.Jack Wei, General Manager of Informa Markets Beijing announced Medtec's new development strategy to establ...

2024-07-01 16:08 2025

IFPA Celebrates Success of the 7th IFPA Conference 2024

STOCKHOLM, July 1, 2024 /PRNewswire/ -- IFPA (The International Federation of Psoriasis Associations) concluded its highly anticipated 7th IFPA Conference on World Psoriasis and Psoriatic Arthritis, held fromJune 27 to 29, 2024, in Stockholm, Sweden. Established in 2006, the conference has become...

2024-07-01 16:00 1757

IASO Bio Presented Clinical Data and Single-cell Analysis of Equecabtagene Autoleucel for the Treatment of Central Nervous System Autoimmunity in Oral Presentation at EAN Congress 2024

SHANGHAI, NANJING, CHINA, and SAN JOSE, Calif., July 1, 2024 /PRNewswire/ -- IASO biotechnology ("IASO Bio"), a biopharmaceutical company engaged in discovering, developing, manufacturing and marketing innovative cell therapies and antibody products, presented the clinical data and single-cell an...

2024-07-01 15:43 1484

National Cancer Society Malaysia and Gene Solutions Forge Partnership to Expand Multi-Cancer Early Detection Awareness and Access

KUALA LUMPUR, Malaysia, July 1, 2024 /PRNewswire/ -- National Cancer Society Malaysia (NCSM) and Gene Solutions are pleased to announce the signing of a Memorandum of Understanding (MOU) to collaborate on expanding awareness and enabling access to multi-cancer early detection (MCED) testing for t...

2024-07-01 12:55 14175

Egg White Rice - an Innovative Food for the Health-Conscious

BANGKOK, July 1, 2024 /PRNewswire/ -- Chula   Faculty of Allied Health Sciences has launched a ready-to-eat flourless rice innovation made from egg whites, branded as"eggyday ".  This product is low in...

2024-07-01 11:56 2183

SCG Cell Therapy Announces FDA IND Clearance of SCG142, a next-generation HPV-specific TCR T cell therapy for patients with HPV-associated solid tumors

SINGAPORE, July 1, 2024 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers, today announced that U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) appl...

2024-07-01 10:56 1992

Transforming Healthcare with AI: YiduTech's Gong Rujing at Summer Davos

DALIAN, China, July 1, 2024 /PRNewswire/ -- "AI in healthcare is extremely challenging. For companies, it requires not only solving scientific problems but also understanding AI technology and respecting the complexity of the healthcare industry." At the 15th Annual Meeting of the New Champions, ...

2024-07-01 10:17 11186

Yidu Tech Announces Annual Results for FY 2024: Existing Business Achieves First Full-Year Profit on Adjusted EBITDA

HONG KONG, June 31, 2024 /PRNewswire/ -- Yidu Tech Inc. ("Yidu Tech" or the "Company", together with its subsidiaries and consolidated affiliated entities, the "Group", HKEX: 2158) announced its annual results for the fiscal year ended 31 March 2024 ("FY2024" or the "Reporting Period"). The manage...

2024-07-01 09:05 18192

CBC-Backed Hasten Biopharmaceutical Announces Acquisition of 14 Celltrion Legacy Products

The deal leverages CBC's hands-on "investor-operator" approach to accelerate portfolio companies' asset acquisition and strategic international expansion SINGAPORE, July 1, 2024 /PRNewswire/ -- CBC Group ("CBC"), Asia's largest healthcare-dedicated asset management firm headquartered inSingapore,...

2024-07-01 09:03 1802

ANYTIME FITNESS LAUNCHES "REAL LIFE NEVER STOPS. ANYTIME STARTS NOW."

– REMINDING US THAT FITNESS IS NOT A WANT, IT'S A NEED. SINGAPORE, July 1, 2024 /PRNewswire/ -- Global brand Anytime Fitness sends a wake-up call with its latest campaign, 'Real Life Never Stops. Anytime Starts Now.'. The campaign was designed to inspire individuals to prioritize their health, n...

2024-07-01 09:00 1856

Pierre Fabre Laboratories announce granting of European marketing authorization for OBGEMSA™ (vibegron) in overactive bladder.

CASTRES, France, June 28, 2024 /PRNewswire/ -- The European Commission (EC) has authorized the marketing of OBGEMSA™ (vibegron) by Pierre Fabre Laboratories for the symptomatic treatment of overactive bladder syndrome in adults, a particularly debilitating condition affecting over 70 million pati...

2024-06-28 23:55 3346

Comprehensively Covering Multiple Myeloma: IASO Bio's GPRC5D CAR-T Product RD118 Receives IND Approval from NMPA

NANJING, China, SHANGHAI and SAN JOSE, Calif., June 28, 2024 /PRNewswire/ -- IASO Biotechnology ("IASO Bio"), a biopharmaceutical company engaged in discovering, developing, manufacturing, and marketing innovative cell therapies and antibody products, today announces thatthe investigational new d...

2024-06-28 18:59 2148

DPC Dash - Domino's Pizza China Expansion Hits 900 Stores in Mainland China

HONG KONG, June 28, 2024 /PRNewswire/ -- DPC Dash Ltd -Domino's Pizza China ("DPC Dash" or the "Company") (1405.HK), Domino's Pizza's exclusive master franchisee in the China Mainland, the Hong Kong Special Administrative Region of China, and the Macau Special Administrative Region of China, today...

2024-06-28 18:37 4153

Hasten Announces Acquisition of 14 Celltrion Legacy Products, Accelerating its Business Expansion in the Pan-Asia Area

SHANGHAI, June 28, 2024 /PRNewswire/ -- Hasten Biopharmaceutical Co., Ltd. (referred to as "Hasten") announced today that it has successfully acquired the asset rights of 14 branded products across Pan-Asia countries and regions from Celltrion, a Korean biopharmaceutical company. According to the...

2024-06-28 16:26 7090
1 ... 66676869707172 ... 847

Week's Top Stories